Private Equity after Medical School: Possible or a pure Utopia?

Hello. I am an EU based second year Medical student, with a previous degree in Pharmacology. After obtaining my MD i wish to pursue a career either in PE or VC (always linked to Pharma/Biotech). I feel i would thourougly enjoy a career that calls on both of my interests: Medicine and Business.

Finance is not new to me. I read a lot, and for the past years, i have been focusing on expanding my knowledge on both public and private markets. Additionally, i am studying in my free time for the Investment Management Certificate, in an attempt to help me get into summer intership.

Can anyone shed some light on how i can best approach this career?

What can I do in the meantime (eg including summer internships)? Researching i understand that commonly one transitions to PE from IB, is this the path i should also be looking at?

I chose this path as an alternative to a PhD, as i felt (and still do) that an MD course focuses on more areas of Life Sciences and is less specialised. Moreover, I felt i would have greater career choice as an MD vs PhD.

Basically, is this doable? Or should i consider leaving medical school?

Thanks in advance for any replies and suggestions.

ps. Just ask if you want additional information!

2 Comments
 

I think you'll make a killing, mostly in venture. I'd get both and work your way into VC funds in your niche. You'll kill it with a mix of pharma, MD and VC.

Global buyer of highly distressed industrial companies. Pays Finder Fees Criteria = $50 - $500M revenues. Highly distressed industrial. Limited Reps and Warranties. Can close in 1-2 weeks.
 

Earum dolore qui consequatur cupiditate nesciunt non eius. Iusto qui itaque magni aut sunt quod. Eaque eius quod a facere alias. Enim autem ducimus tenetur. Quasi ex reiciendis vel distinctio.

Ducimus sapiente sunt sapiente velit officia. Excepturi aut aut omnis ea voluptas distinctio labore. Sed vel debitis voluptatem corrupti.

Quis quis officia quia accusantium asperiores placeat. Voluptatem est dolore rem et qui dignissimos quia quia. Debitis laboriosam tenetur impedit vero. Sint alias ullam et aut itaque quis voluptates in. Mollitia itaque deserunt doloremque aut facere dolore non.

Career Advancement Opportunities

July 2026 Private Equity

  • The Riverside Company 99.6%
  • Blackstone Group 99.3%
  • KKR (Kohlberg Kravis Roberts) 98.9%
  • Warburg Pincus 98.5%
  • Vista Equity Partners 98.1%

Overall Employee Satisfaction

July 2026 Private Equity

  • Blackstone Group 99.6%
  • KKR (Kohlberg Kravis Roberts) 99.2%
  • The Riverside Company 98.9%
  • Ardian 98.5%
  • Starwood Capital Group 98.1%

Professional Growth Opportunities

July 2026 Private Equity

  • Bain Capital 99.6%
  • The Riverside Company 99.3%
  • Blackstone Group 98.9%
  • Starwood Capital Group 98.5%
  • Vista Equity Partners 98.1%

Total Avg Compensation

July 2026 Private Equity

  • Principal (9) $653
  • Director/MD (24) $547
  • Vice President (99) $363
  • 3rd+ Year Associate (104) $281
  • 2nd Year Associate (235) $272
  • 1st Year Associate (411) $229
  • 3rd+ Year Analyst (33) $157
  • 2nd Year Analyst (97) $134
  • 1st Year Analyst (272) $124
  • Intern/Summer Associate (38) $81
  • Intern/Summer Analyst (356) $61
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
DrApeman's picture
DrApeman
98.9
6
CompBanker's picture
CompBanker
98.9
7
dosk17's picture
dosk17
98.9
8
GameTheory's picture
GameTheory
98.9
9
Betsy Massar's picture
Betsy Massar
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”